Page last updated: 2024-10-21

5-(n,n-hexamethylene)amiloride and Chronic Illness

5-(n,n-hexamethylene)amiloride has been researched along with Chronic Illness in 1 studies

5-(N,N-hexamethylene)amiloride: inhibitor of Na+-H+ exchange; has anti-HIV-1 activity
5-(N,N-hexamethylene)amiloride : A member of the class of pyrazines that is amiloride in which the two amino hydrogens at position N-5 are replaced by a hexamethylene moiety, resulting in the formation of an azepane ring.

Research Excerpts

ExcerptRelevanceReference
"Right ventricular hypertrophy was apparent after both 1 and 4 weeks of hypoxia."1.29Increased resistance to acute respiratory acidosis in isolated cardiac muscle following chronic hypoxia-induced hypertrophy. ( Bateman, NT; Neville, E; Ward, JP, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neville, E1
Bateman, NT1
Ward, JP1

Other Studies

1 other study available for 5-(n,n-hexamethylene)amiloride and Chronic Illness

ArticleYear
Increased resistance to acute respiratory acidosis in isolated cardiac muscle following chronic hypoxia-induced hypertrophy.
    Cardiovascular research, 1996, Volume: 31, Issue:5

    Topics: Acidosis, Respiratory; Amiloride; Animals; Chronic Disease; Hypertrophy, Right Ventricular; Hypoxia;

1996